IM Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- IM Therapeutics's estimated annual revenue is currently $210k per year.
- IM Therapeutics's estimated revenue per employee is $70,000
Employee Data
- IM Therapeutics has 3 Employees.
- IM Therapeutics grew their employee count by -25% last year.
IM Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | VP, R&D | Reveal Email/Phone |
3 | VP, Clinical Development | Reveal Email/Phone |
4 | Co-founder/Chief Medical Officer | Reveal Email/Phone |
5 | Co-founder/Chief Scientific Officer | Reveal Email/Phone |
6 | CFO/COO | Reveal Email/Phone |
IM Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $12.3M | 88 | 13% | N/A | N/A |
#2 | $1.2M | 14 | -33% | N/A | N/A |
#3 | $5.3M | 50 | -26% | $29.3M | N/A |
#4 | $24.7M | 164 | -5% | $45.2M | N/A |
#5 | $4.8M | 43 | 5% | N/A | N/A |
#6 | $77M | 0 | N/A | $866M | N/A |
#7 | $0.3M | 4 | -33% | N/A | N/A |
#8 | $3.9M | 35 | 25% | N/A | N/A |
#9 | $234.6M | 1197 | 8% | N/A | N/A |
#10 | $18.6M | 133 | -16% | $23.3M | N/A |
What Is IM Therapeutics?
IM Therapeutics is building an HLA-directed platform for new therapies. We have demonstrated early effectiveness in type 1 diabetes and are building a pipeline of targeted therapies across autoimmune diseases.
keywords:N/AN/A
Total Funding
3
Number of Employees
$210k
Revenue (est)
-25%
Employee Growth %
N/A
Valuation
N/A
Accelerator
IM Therapeutics News
2022-04-20 - OMass Therapeutics: The 21st Century Vertex? :: In Vivo
Deegan studied science at the University of Cambridge but decided early on not to pursue academia. Let's just say that I'm better with my brain...
2022-04-20 - Viking Therapeutics (VKTX) Q1 2022 Earnings Call Transcript
Good day, and welcome to the Viking Therapeutics 2022 first quarter ... Finally, I'm happy to report that even while expanding our clinical...
2022-04-20 - Kelonia Therapeutics Launches with $50 Million Series A ...
I'm incredibly excited about the potential of Kelonia's platform and team to vastly expand the utility of gene therapies to treat oncology,...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.2M | 3 | 0% | N/A |
#2 | $0.4M | 4 | -20% | N/A |
#3 | $0.3M | 4 | -20% | N/A |
#4 | $0.3M | 4 | 0% | N/A |
#5 | $0.3M | 4 | -20% | N/A |